Athenex Inc

NASDAQ:ATNX

1.33

-0.04 (-2.92%)

7:54:22 PM EDT: $1.40 +0.07 (+5.26%)

Products

Athenex Announces FDA Approval of Klisyri for the Treatment of Actinic Keratosis on the Face or Scalp

Published: 12/15/2020 13:56 GMT

ATNX

Athenex Inc (ATNX) - Athenex Announces FDA Approval of Klisyri® (tirbanibulin) for the Treatment of Actinic Keratosis on the Face Or Scalp.
Athenex Inc - Klisyri Will Be Launched in Partnership With Almirall in U.S. During Q1 Of.